MSFT 435.0 0.7061% AAPL 230.65 -1.2924% NVDA 139.965 -0.9097% GOOGL 176.965 4.2934% GOOG 178.65 4.3882% AMZN 193.73 1.5197% META 594.31 0.1736% AVGO 177.28 -1.0935% TSLA 262.2401 1.0481% TSM 195.14 -0.914% LLY 831.501 -7.977% V 291.3 3.3418% JPM 224.685 0.8008% UNH 564.77 0.4696% NVO 113.15 1.0448% WMT 81.58 -0.1469% LVMUY 134.2 -1.4033% XOM 117.0342 -0.2096% LVMHF 670.0 -1.3008% MA 513.51 1.4281%

Bio Essence Corporation

Healthcare US BIOE

0.495USD
-0.105(17.50%)

Last update at 2024-10-30T17:49:00Z

Day Range

0.410.61
LowHigh

52 Week Range

0.241.25
LowHigh

Fundamentals

  • Previous Close 0.60
  • Market Cap19.38M
  • Volume26000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.89067M
  • Revenue TTM0.96M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 0.30M
  • Diluted EPS TTM-0.02

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.80638M -0.64426M -0.59254M -1.70011M -
Minority interest - - - - -
Net income -0.80968M -0.64756M -0.59584M -1.70341M -
Selling general administrative 1.17M 1.15M 1.06M 1.74M -
Selling and marketing expenses - - - - -
Gross profit 0.38M 0.30M 0.23M 0.17M -
Reconciled depreciation 0.05M 0.04M 0.03M 0.03M -
Ebit - -0.85753M -0.83257M -1.71788M -1.50031M
Ebitda -0.72936M -0.56990M -0.51735M -1.66847M -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.78280M -0.84891M -0.83069M -1.56838M -
Other operating expenses - - - - -
Interest expense 0.02M 0.04M 0.04M 0.00000M -
Tax provision 0.00330M 0.00330M 0.00330M 0.00330M -
Interest income - - 0.00001M 0.00001M -
Net interest income -0.02837M -0.04826M -0.06630M -0.02405M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.00330M 0.00330M 0.00330M 0.00320M
Total revenue 0.99M 0.89M 0.96M 0.83M -
Total operating expenses 1.77M 1.74M 1.79M 2.39M -
Cost of revenue 0.60M 0.59M 0.73M 0.65M -
Total other income expense net 0.00480M 0.25M 0.30M -0.10768M -
Discontinued operations - - - - -
Net income from continuing ops -0.80968M -0.64756M -0.59584M -1.70341M -
Net income applicable to common shares - -0.64756M -0.59584M -1.70341M -1.45869M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1.55M 1.70M 1.85M 2.29M -
Intangible assets 0.00080M 0.00104M 0.00739M 0.02M -
Earning assets - - - - -
Other current assets - - 0.00473M 0.04M 0.06M
Total liab 4.79M 4.13M 3.63M 3.38M -
Total stockholder equity -3.23841M -2.42874M -1.78117M -1.08533M -
Deferred long term liab - - - - -
Other current liab - 0.07M 0.36M 0.41M 0.62M
Common stock - 0.00330M 0.00330M 0.00332M 0.00323M
Capital stock 0.00330M 0.00330M 0.00330M 0.00332M -
Retained earnings -8.16859M -7.35892M -6.71135M -6.11551M -4.41211M
Other liab - - 0.23M 0.61M -
Good will - - - - -
Other assets - 0.04M 0.04M 0.04M 0.06M
Cash 0.00626M 0.00030M 0.00532M 0.02M -
Cash and equivalents - - - - -
Total current liabilities 3.56M 2.76M 1.89M 1.33M 0.85M
Current deferred revenue - - - - -
Net debt 3.45M 2.68M 1.51M 0.67M -
Short term debt - - - - -
Short long term debt 3.22M 2.43M 1.30M 0.69M -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - 1.39M 1.47M 1.64M 0.10M
Total current assets 0.20M 0.26M 0.33M 0.60M 0.83M
Long term investments - - - - -
Net tangible assets - -2.42977M -1.78856M -1.10343M 0.14M
Short term investments - - - - -
Net receivables 0.00560M 0.02M 0.05M 0.02M 0.18M
Long term debt 0.24M 0.25M 0.21M - -
Inventory 0.18M 0.21M 0.27M 0.52M 0.58M
Accounts payable 0.05M 0.06M 0.05M 0.08M 0.06M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 1.34M 1.44M 1.52M 1.69M -
Capital lease obligations 1.16M 1.28M 1.44M 1.59M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.05912M -0.11680M -0.00737M -0.02765M -
Change to liabilities - 0.01M -0.02524M 0.02M 0.05M
Total cashflows from investing activities - -0.11680M -0.00737M -0.02765M -0.08892M
Net borrowings - 1.41M 0.83M 0.57M 0.11M
Total cash from financing activities 0.77M 1.41M 0.73M 0.93M 0.21M
Change to operating activities - -0.76144M -0.61311M 0.18M 0.36M
Net income -0.80968M -0.64756M -0.59584M -1.70341M -1.45869M
Change in cash 0.00596M -0.00502M -0.01084M 0.00649M -0.71355M
Begin period cash flow 0.00030M 0.00532M 0.02M 0.00967M -
End period cash flow 0.00626M 0.00030M 0.00532M 0.02M 0.00967M
Total cash from operating activities -0.70682M -1.29412M -0.73274M -0.89692M -0.83100M
Issuance of capital stock - - 0.00000M 0.36M -
Depreciation 0.05M 0.04M 0.03M 0.03M 0.04M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.03M 0.06M 0.25M 0.12M 0.16M
Change to account receivables 0.01M 0.02M -0.02449M 0.01M 0.03M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - -0.00621M 0.23M 0.45M 0.00619M
Capital expenditures 0.06M 0.12M 0.00737M 0.03M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.07M -0.45041M -0.17773M 0.48M -
Stock based compensation - 0.00000M 0.00889M 0.08M -
Other non cash items -0.01672M -0.23947M 0.00962M 0.06M -
Free cash flow -0.76594M -1.41361M -0.74011M -0.92457M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BIOE
Bio Essence Corporation
-0.105 17.50% 0.49 - - 20.28 - 22.92 -24.3825
ZTS
Zoetis Inc
0.81 0.45% 182.08 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.1 0.30% 32.87 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
- -% 162.43 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
0.04 0.29% 13.89 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States and internationally. It targets healthcare practitioners with herbal products in the form of granules, capsules, pills, and tablets; offers special formulation, original equipment manufacturing, and private label services to practitioners and other companies; and produces and distributes health supplement products. The company sells its products through TCM practitioners, online websites, brick-and-mortar stores, and other channels. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

Bio Essence Corporation

8 Studebaker Drive, Irvine, CA, United States, 92618

Key Executives

Name Title Year Born
Ms. Yin Yan CEO, CFO & Chairman 1975
Mr. Tuan Tran VP of Operations 1975

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.